Valuation (55%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 85.13 | N/A |
| PEG Ratio (TTM) | -1.37 | N/A |
| P/S Ratio (TTM) | 2.20 | N/A |
| P/B Ratio (TTM) | 1.98 | N/A |
| P/FCF Ratio (TTM) | 10.92 | N/A |
| Price to 5YR AVG Earnings Ratio | 105.99 | N/A |
| Price to 5YR AVG FCF Ratio | 5.94 | N/A |
Profitability (25%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.35% | N/A |
| ROE (TTM) | 2.21% | N/A |
| Net Profit Margin (TTM) | 2.59% | N/A |
| ROIC 5YR AVG | 5.53% | N/A |
Growth (63%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 43.35% | -61.59% | 405.94% |
| Revenue | 5.27% | 5.56% | 1.48% |
| Net Income | 65.15% | -62.72% | 414.26% |
| Cash Flow | 17.23% | 8.86% | 1.74% |
Health (33%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.25 | N/A |
| Quick Ratio (TTM) | 1.20 | N/A |
| D/E Ratio (TTM) | 4.22 | N/A |
| Interest Coverage (TTM) | 0.79 | N/A |
| Piotroski F-Score | 7 | N/A |
| Altman Z-Score | 0.48 | N/A |
| LTL to 5YR AVG FCF | 11.78 | N/A |
| Shares Outstanding Growth 5YR AVG | 3.04% | N/A |